ProKidney Corp/$PROK
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About ProKidney Corp
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
- Ticker
- $PROK
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 231
- Headquarters
- Winston-Salem, United States
- Website
- prokidney.com
ProKidney Corp Metrics
BasicAdvanced
$223M
-
-$0.56
1.75
-
Price and volume
Market cap
$223M
Beta
1.75
52-week high
$2.95
52-week low
$0.87
Average daily volume
1.4M
Financial strength
Current ratio
8.356
Quick ratio
8.037
Long term debt to equity
0.011
Total debt to equity
0.016
Interest coverage (TTM)
-9,327.16%
Profitability
EBITDA (TTM)
-170.37
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-10,288.39%
Operating margin (TTM)
-21,664.55%
Effective tax rate (TTM)
0.61%
Management effectiveness
Return on assets (TTM)
-35.66%
Return on equity (TTM)
-58.96%
Valuation
Price to revenue (TTM)
196.858
Price to book
-0.25
Price to tangible book (TTM)
-0.25
Price to free cash flow (TTM)
-1.008
Free cash flow yield (TTM)
-99.20%
Free cash flow per share (TTM)
-1.056
Growth
Revenue change (TTM)
55.22%
Earnings per share change (TTM)
-1.21%
3-year earnings per share growth (CAGR)
1.88%
What the Analysts think about ProKidney Corp
Analyst ratings (Buy, Hold, Sell) for ProKidney Corp stock.
Analyst projections of the future price of ProKidney Corp stock.
ProKidney Corp Financial Performance
Revenues and expenses
ProKidney Corp Earnings Performance
Company profitability
Upcoming events
No upcoming events
ProKidney Corp News
AllArticlesVideos
Funds containing ProKidney Corp
Fund name | Fund size | $PROK weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.00% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.